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Abstract 
Frailty in older people is associated with a vulnerability to adverse events.  While ageing is 
associated with a loss of physiological reserves identifying those with the syndrome of frailty 
has the potential to assist clinicians tailor treatments to those at risk of future decline into 
disability with increased risk of complications, morbidity and mortality.  Sarcopenia is a key 
component of the frailty syndrome and on its own puts older people at risk of fragility 
fractures however the clinical syndrome of frailty affects musculoskeletal and non 
musculoskeletal systems. Hip fractures are becoming a prototype condition in the study of 
frailty.  Following a hip fracture many of the interventions are focused on limiting mobility 
disability and restoring independence with activities of daily living but there are multiple 
factors to be addressed including osteoporosis, sarcopenia, delirium, weight loss.  Established 
techniques of geriatric evaluation and management allow systematic assessment and 
intervention on multiple components by multidisciplinary teams and deliver the best 
outcomes. Using the concept of frailty to identify older people with musculoskeletal 
problems as at risk of a poor outcome assists in treatment planning and is likely to become 
more important as effective pharmacological treatments for sarcopenia emerge. 
This review will focus on the concept of frailty and its relationship with functional decline, as 
well as describing its causes, prevalence, risk factors and potential clinical applications and 
treatment strategies.    
  Key words 
Fragility fracture, frailty, functional decline, screening, older adult, exercise therapy, dietary 
therapy  
Word count 
9,401 words (word limit=9,400) 
  
Musculoskeletal health, frailty and functional decline 
Many of the common musculoskeletal problems of old age including osteoporosis, 
osteoarthritis and fragility fractures are associated with mobility disability [1] and can spiral 
into functional decline and disability. As the population ages and patients present with more 
and more comorbidities it is important for clinicians  to be able to identify quickly those who 
require resource intensive multi-component interventions delivered by teams from those who 
require a short physiotherapy program or a self-management program.  The presence of 
frailty is starting to guide treatment for health conditions in older people because it has been 
shown that frailty can predict response to treatment and likelihood of adverse complications 
[2].  
Frailty is a term first used in the medical literature in the1970’s which is receiving increasing 
focus in research and clinical practice due to its ability to predict poor outcomes in older 
people of relevance to society such as falls, disability, functional decline, hospitalization, 
institutionalisation and mortality [3-11].  While linked to theories of aging, it has come to be 
thought of as a separate condition indicating abnormal aging and poor health and therefore a 
potential target for interventions and therapies to slow or reverse its progression [12]. In 
addition, it is known to occur in tandem with other clinical conditions of aging including 
sarcopenia, functional decline, neuroendocrine disorders, and immune dysfunction [13].   
Frailty has been associated with increased risk of having a fall (OR 2.02 95% CI 11.44 to 
2.83) and experiencing a greater number of fractures in community dwelling older adults (OR 
3.67 95% CI 1.47 to 9.15) [14]. The costs to the US of fragility fractures seen in frail older 
adults such as hip fracture has been estimated as greater than $US 12 billion per year [15].  
Costs of providing hospital, medical, and community services for frail older adults compared 
to non-frail older adults have been estimated at up to an additional ₤109 per week in the 
United Kingdom [16].  Therefore, while debate continues regarding the identification and 
aetiology of frailty, the importance of developing adequate means of addressing this 
increasing burden on the healthcare system cannot be overestimated.  
Definitions of frailty 
The recent push to standardise definitions of frailty has resulted in a number of reviews of 
this topic published recently [3, 12, 13, 17-19].  Two models of frailty dominate the literature. 
Fried et al. [10] has proposed a phenotype model of frailty which evolved from factors such 
as chronic disease, and musculoskeletal changes, leading to reduced physical activity and 
energy expenditure, abnormalities in neuroendocrine regulation, and chronic under-nutrition.  
The consequences of the above conditions include loss of weight and muscle mass which 
further impact upon musculoskeletal changes producing the cyclical nature of the model.  
Based upon this model, Fried proposed five criteria for use in research and clinical settings 
including unintentional weight loss or loss of muscle mass (i.e. sarcopenia), weakness, poor 
endurance or exhaustion, slowness, and low activity levels.  From this phenotype, a practical 
instrument for assessing performance in these areas based on five measures included in the 
Cardiovascular Health Study has been created[10].  This phenotype was validated with 5,317 
participants aged 65 years and older, and was associated with an increased risk of mortality 
(HR = 6.47 95%CI 4.63 to 9.03, p<0.0001), first hospitalization (HR 2.25 95%CI 1.94 to 
2.62 p<0.0001), first fall (HR 2.06 95%CI 1.64 to 2.59 p<0.0001), increasing ADL disability 
(HR 5.61 95% CI 4.50 to 7.00 p<0.0001), and worsening mobility (HR 2.68, 95% CI 2.26 to 
3.18 p<0.0001) over three years of follow up[10].  Since that study, this criteria or similar has 
been shown to be associated with increased risk of mortality, admission to residential aged 
care, hospitalisation, declining ability to perform ADLs and instrumental ADLs, risk of falls 
and declining mobility in community-dwelling older adult populations of both men and 
women[4, 5, 20-22].   
The other important model was developed by Rockwood et al. [23] and is often described as 
the accumulation model.  It takes into account the interplay between “assets” or components, 
which help an older person to remain living in the community and “deficits” or components 
which are detrimental to their ability to live independently.  These include biomedical factors 
(such as health, illness, and disability) as well as psychosocial factors (such as dependence on 
others and resources available).  Accordingly, it is this balance between the assets and the 
deficits which will determine whether someone is able to remain in the community or not – if 
the deficits outweigh the assets for an individual, they will not be able to maintain their 
position in the community and require institutional input.  This theory has seen the 
development of instruments for assessing the degree of frailty in individuals or populations, 
commonly referred to as frailty indexes.  For a deficit to be considered to contribute to frailty 
it must be acquired, related to health status, and increase with age but not so rapidly that 
saturation is reached at a relatively young age limiting the specificity of the index [24]. 
Commonly, the frailty indexes list over 70 potential deficits including aspects of general 
health and disease status, ability in ADLs, and psychological symptoms. A 92 item version 
[25] validated in 1468 participants from a general population sample (Canadian Study of 
Health and Aging), found an association with time to death and increasing frailty index score 
(r=-0.234, p<0.0001) which was greater than that seen between time to death and increasing 
age (r=-0.088, p<0.05), highlighting the usefulness of the concept of frailty above that of age 
to predict adverse outcomes.  Similarly, Evans et al. found an association between frailty 
measured by a shorter 55 item frailty index and mortality in a smaller sample (n=752) of 
older adults admitted to an acute care setting over five years (HR 1.05, 95% CI 1.04 to 
1.07)[9]. Velanovich et al. [26] found a significant increase in risk of mortality with each unit 
increase in frailty measured using an 11 item index in a range of surgical inpatient admissions 
(p<0.0001).  For orthopaedic surgical admissions, the OR of mortality for each unit increase 
in frailty ranged from 3.36 (95% CI 2.64 to 4.27) to 11.68 (95% CI 7.81 to 17.46), dependent 
on the complexity of the operation. Therefore a wide range of frailty indexes have predictive 
validity, providing evidence for the accumulated deficit models of frailty.  
Development of frailty 
There has been much debate on the factors that contribute to the pathogenesis of frailty, due 
in part to the variety in definitions of frailty in the literature, and current models often include 
psychosocial, as well as physical components [18, 19, 27, 28]. Nevertheless, physical decline 
and disability remains one of the key predictive features in the development of frailty and so 
musculoskeletal conditions are important considerations [19, 28].   An overview of some of 
the inter-related factors promoting development of the frailty syndrome and its consequences 
are illustrated in figure 1 [29].  
A key cause of frailty and physical decline in older adults is sarcopenia [3, 27, 30-32].  
Sarcopenia (from the Greek words sarx meaning flesh and penia or poverty) refers to the loss 
of muscle mass associated with aging, but recent definitions include aspects of reduction in 
mobility, and reduction in appendicular lean mass [30, 32, 33].  Sarcopenia has been found to 
be an independent predictor of physical disability and development of mobility disorders, as 
well as reduced bone mineral density [27, 34, 35].  Diagnosis is usually through identifying 
loss of lean body mass (e.g. less than the twentieth percentile for young healthy adults [34]) 
although it is important to note that muscle strength is not always correlated to total lean mass 
[27, 30].  Therefore a measurement of physical performance and muscle function is required, 
such as a reduced mobility or gait speed (e.g. gait speed less than 1ms-1) [34].  Sarcopenia 
itself is a multi-system syndrome brought on by a number of inter-related factors[32], 
including an increasing inflammatory state, reducing protein synethsis and promoting 
apoptosis, reduced growth hormone, testosterone and insulin-like growth factor-1 (IGF-1) 
reducing muscle growth and muscle strength, and disorders in nervous system control of 
muscular function.  In addition, anorexia and malnutrition promotes loss of weight and 
muscle mass.  A key factor promoting all these dysfunctions is immobility and lack of 
exercise, which is a driving factor behind most of these physical and immunologic changes, 
and  promoting the cyclical decline seen in the condition, as illustrated in figure 1[32].  While 
traditionally associated with a low body mass, sarcopenia is increasingly being identified in 
obese individuals which results from the substitution of muscle mass for fat mass and related 
immobility and lack of use of muscular systems[27, 32].  A relationship is seen between 
frailty and low or very high BMI, with rates lowest in those with a BMI between 20 and 
29.9[36].  In addition, a relationship is seen between high waist circumference (defined as 
greater than 88cm in women and greater than 102 cm in men) and increased frailty [36].   
Chronic low level inflammation has also been proposed as a causative factor [37], which 
plays a key role in both the aging process and the development of both sarcopenia and frailty 
[37]. A number of the signs and symptoms of frailty (low muscle strength, exhaustion, and 
unintentional weight loss) are also seen with increased pro-inflammatory markers, especially 
IL-6 [37].  Potential pathologic causes of chronic low level inflammation proposed include 
persistent infection with the herpes virus cytomegalovirus (CMV) [37].  In addition, other 
chronic diseases such as atherosclerosis, Alzheimer’s disease, cancer, and autoimmune 
diseases have been shown to contribute to inflammatory status and frailty[27, 37].  
Functional decline and its role in frailty 
There is growing evidence that the development of functional limitations is such as problems 
with mobility are one of the first markers for frailty [13, 37].  While disability and functional 
limitations have been identified as a highly correlated with frailty, the concept is now 
regarded as distinct to that of frailty, but sharing many common pathways for development 
[38].  Functional decline or disability is usually described as a loss of an individual’s ability 
to perform basic tasks required to maintain independence in living status (usually described 
as activities of daily living or ADLs) [39].  Basic ADLs include everyday tasks such as 
bathing, dressing, feeding, continence, toileting, and mobility [39]. Instrumental ADLs 
require higher level function and include tasks such as banking, shopping, and driving [39]. 
Measuring functional decline is of interest, similarly to the concept of frailty, for its ability to 
predict future mortality, morbidity, hospitalisation and institutionalisation [40-42].  Increased 
risk is associated with cognitive impairment, hospitalisation, poly-pharmacy, older age, 
history of fractures, malnutrition, low physical activity, lower strength, and depression[41-
49].Musculoskeletal conditions have long been recognised as a major cause of functional 
impairment and disability. The total number of disability adjusted life years associated with 
musculoskeletal conditions worldwide has been estimated as over 30,000,000, and they 
remain one of the ten leading causes of disability worldwide [50].  In recent study in France 
over a quarter of the population reported at least one musculoskeletal condition, with 
osteoarthritis and lower back pain the most commonly reported disorders [51].  Disability 
was common among those with rhematic and musculoskeletal conditions, with up to 22% of 
those with osteoarthritis and inflammatory arthritis difficulty mobilising compared with only 
5% of those without the conditions.  Participants with musculoskeletal and rheumatic 
conditions also commonly experienced impairments in most basic functional activities, 
including shopping, doing housework, carrying objects, and needed more assistance from 
family and health professionals, and there is evidence of increasing decline over time [45, 
51]. Particular risk factors for decline in arthritis suffers include pain, reduced muscle 
strength and joint instability, range of joint movement, comorbidities including 
cardiovascular conditions, diabetes and stroke, high body weight, avoidance of exercise, and 
female gender, factors which are also commonly identified in the aetiology of frailty[45].  
An increasingly important contributor to the burden of musculoskeletal conditions is fragility 
fractures.  Worldwide there were over 5.2 million non-traumatic fractures in 2010 with over 
half of those attributable to fractures of the hip and spine [52].  A recent review has 
highlighted the devastating effect of hip fractures on the long-term function of older adults, 
with 29% of cases not regaining their pre-fracture level of function in ADL[53]. Over 40% of 
patients had not regained their pre-fracture level of mobility at 1 year following fracture, and 
over a third were unable to walk independently due to the fractures.  In addition, ongoing 
pain is widespread in this population, with 47% reporting pain one or more years following 
the fracture.  This widespread pain and difficulty mobilising are likely markers for overall 
decreasing physical exercise and function, which are independently associated frailty.   As a 
result of this widespread functional decline, a large proportion will become increasingly 
dependent on community and residential care services so any identification of reversible 
components will impact not just on individuals but on the community as well.  
How is frailty identified or diagnosed? 
Given the rapid aging of the population, the creation of tools to identify frail older people has 
received increasing focus over the past decades [12].  Recent recommendations suggest that 
all persons over the age of 70 years old should be screened for frailty and in addition, persons 
of any age where significant weight loss (≥5% of total body weight) occurs unplanned and as 
a result of chronic disease [28].  In addition, low physical activity, and functional decline 
suggest problems, and older adults with musculoskeletal conditions should be screened.  
Screening should ideally occur early, before significant dependence in basic ADLs has 
developed, to develop treatment plans to prevent further or reverse decline and plan for future 
increased health and social support [28].  There are currently many simple rapid screening 
tools available that are validated in older adult populations (see Table 1) [28]. These tools are 
designed to be quickly administered and based mostly on self-report of the patient, although 
the Cardiovascular Health Study Frailty Screening Scale [10], and Gérontopôle Frailty 
Screening Tool [54] require performance based measures such as gait speed and grip 
strength, which may pose challenges dependant on access to relevant space and equipment in 
a clinical setting.  In addition, the Clinical Frailty Scale and Gérontopôle Frailty Screening 
Tool require clinical judgement in their scoring systems, requiring a degree of experience and 
knowledge to be used effectively [54, 55].  
In addition to the four rapid screening tools highlighted above, there are over 30 different 
tools published for the identification of those at risk of frailty, ranging from single outcome 
measures, to large multi-component assessment instruments [3, 12, 13, 18, 19, 56].  A 
number of reviews have been published outlining the variety of instruments available and 
their validity [17-19].  While a large variety of tools to assess frailty in populations exist, 
there are two main groups [13].  One includes either single or multicomponent assessments of 
physical ability, the other considers a combination of physical, social, cognitive, and other 
factors in the identification and assessment of frailty [13, 28, 38]. A recent review focused on 
instruments to assess frailty for use in measuring outcomes in clinical practice and research, 
with a view to promoting interventions to prevent or manage frailty in practice [19].  De 
Vries et al. [19] identified 20 different instruments (see Table 2) and assessed their 
clinimetric properties by assessing content validity, internal consistency, construct validity, 
agreement, reliability, responsiveness, and interpretability.  They subscribed to current 
multidimensional models of frailty, which consider impairments in multiple domains of the 
individual as contributing to frailty, including physical, psychological, and social domains, 
and assessed the instruments’ coverage of all of these areas.  They found that only five 
instruments included items on all three of these frailty domains: the Frailty Index (FI) or 
accumulated deficits model [25], Groningen Frailty Indicator (GFI) [57], Clinical Global 
Impression of Change in Physical Frailty (CGIC-PF) [58], Geriatric Functional Evaluation 
(GFE) [59], and the Geriatric Functional Evaluation Frailty Index – Comprehensive Geriatric 
Assessment (FI-CGA) [60].  In addition, the majority of the instruments utilized a 
dichotomous scoring system (i.e. frail vs not-frail), which gives minimal relevance for 
measuring change in populations over time [57, 58, 61-69].  Other instruments utilize either 
multiple levels of frailty [10, 59, 60, 70, 71] or use continuous or ordinal scoring scales [25, 
72-75] which may be more relevant to clinicians wanting to determine the level of frailty in 
one patient compared to another, or change in the level of frailty over time.  
More recently, de Vries et al. [76] have created a frailty index based on the deficit which was 
found to significantly correlate with measures of strength and mobility including the Timed-
Up and Go test (r=0.61, p=0.00), Performance Orientated Mobility Assessment (r=-0.70 
p=0.00) and the Cumulative Illness Rating Scale for Geriatrics (r=0.66 p=0.00), however the 
study was small in size (n=24) and further information on how the instrument performs over 
time and in evaluating outcomes from interventions is required.  
How prevalent is frailty? 
Studies report a range of estimates of the frailty of the population, dependent on the 
population studied in addition to which of the number of available instruments to identify 
frailty are used. Table 3 gives a range of estimates of the prevalence of frailty in general 
population samples.  Estimates range from around 3% (using the Fried criteria in a population 
of community-dwelling adults included in the Whitehall II study) up to 52% (in a population 
of community dwelling older adults in Italy using the Marigliano-Cacciafesta 
Polypathological scale) [4, 5, 10, 11, 20, 21, 77-79].  Most studies indicate a level of frailty 
for community-dwelling older adults between 5 and 15%.  Studies have also reported on the 
prevalence of “pre-frailty” in the community dwelling older adult population, a state 
indicating risk of developing frailty in the future and the need for a targeted intervention to 
prevent further decline.  Studies utilizing the SOF and Fried criteria have indicated a high 
prevalence of pre-frailty in the community-dwelling older adult population(approximately 
30%) indicating the presence of risk factors which could lead to future frailty in this 
population, but that current physiological, social and mental resources are adequate to 
maintain their independence in the community [4, 5, 20, 21, 78].  Prevalence of frailty 
increases with age and is almost two times greater in women than in men [80].  Older 
community dwelling older adults the prevalence has been described as over 25% for those 
aged 85 years and over, compared to under 5% in those aged between 65 and 69 years [80].  
In addition, frailty is increased among those with chronic conditions such as congestive heart 
failure, myocardial infarction, peripheral vascular diseases, diabetes, and hypertension, renal 
failure, cancer, and HIV [28, 37].  In addition, older adults with cognitive impairment and 
dementia appear especially at risk of frailty, either through the cognitive impairment 
influencing physical health or a shared etiological factor [37].   
Studies of the prevalence of frailty specifically in populations with musculoskeletal problems 
are fewer in number.  A study of hospitalised older adults found that up to 70% of patients 
admitted to a combined rheumatology and pulmonary ward were identified at risk of frailty 
and likely to benefit from a geriatric intervention, determined by the Groningen Frailty 
Indicator (GFI) [81]. Auais et al. [82] studied the change in frailty related characteristics in 
hip fracture patients between 2001 and 2008, and identified approximately half of exhibited 
significant levels of comorbidities, sarcopenia risk factors, and osteoporosis risk factors.  In 
addition, they identified increasing frailty in the hip fracture population over time, with an 
increase in the prevalence of each frailty-related characteristic (such as older age, admission 
to long term care, number of comorbidities, osteoporosis, sarcopenia, and dementia) of 
between 2 and 14% per year, including a significant increase in the risk of women (OR 1.05, 
95% CI 1.04 to 1.06) and men (OR 1.04 95% CI 1.02 to 1.06) having osteoporosis risk 
factors, as well as having three or more relevant comorbidities (OR 1.07 95% CI 1.06 to 
1.08).    
Frailty rates are higher among people with osteoporosis, likely due to aspects of the shared 
etiological factors of the two conditions such as low physical activity, nutritional deficiency, 
low levels of testosterone, estrogen, sulphate of dihydroepiandrostenedione (S-DHEA), and 
IGF-1, and increased inflammation [83].  Frisoli et al. [83] identified a link between 
osteoporosis, osteopenia and sarcopenia and frailty as identified using the Fried criteria and  
in 257 community-dwelling participants of the Women Health and Aging Study II.  While the 
overall prevalence of frailty in the population was low (n=17, 6.8%), severe 
osteoporosis/osteopenia was high among those identified as frail (n=7, 42%), and lower in the 
pre-frail (n=33, 28%), and the robust group (n=29, 25%), although this did not reach 
statistical significance. In addition, lower skeletal muscle mass has been shown to be 
associated with lower bone mineral content, narrower bones with thinner cortices, and 
decreased bone strength [84].  Previous studies have also identified associations between 
lower bone mineral density and frailty [7, 8, 85], although other studies have indicated that 
the high risk of hip fracture in frail older adults may be more related their increased risk of 
falls rather than reduced BMD [86].  
Frailty has also been indicated to be high in older adults with osteoarthritis, ranging from 26 
to 70% [6, 87].  Frailty was associated with an increased risk of mortality over 12 years in 
older adults with osteoarthritis (HR 1.98 95% CI 1.63 to 2.95, p<0.01) as well in as those 
with no osteoarthritis (HR 1.32 95% CI 1.06 to 1.65, p=0.03) [6]. In addition increased risk 
of osteoporotic fracture has been found in women with osteoarthritis and rheumatoid arthritis, 
however when asked about their self-perceived risk of fracture, women with arthritis 
perceived their risk as similar to women without the conditions of a similar age [88].  In 
addition, those women with arthritis who perceived their risk of fracture as less than those of 
women without arthritis of the same age, actually had a higher than average risk of fracture in 
the study.  Therefore, while clinicians and rheumatologists are aware of the increased risks of 
fracture associated with arthritis, this message may not be getting through to the patients 
themselves which may affect their uptake of recommended preventative measures.  
Treatment strategies 
While effective pharmacological treatment strategies for sarcopenia are under investigation 
[30], the current effective interventions for frail older adults are nutritional therapy and 
resistance training [28].  
Due to the role of poor appetite and resulting poor nutritional intake in the development of 
frailty, nutritional strategies have been highlighted as an important first step in treating frailty 
and pre-frailty [89]. In frail older people, intake of dietary energy and protein be can 
insufficient to meet requirements, and muscle stores of carbohydrate and protein, as well as 
adipose tissue are broken down and utilized to maintain the energy supply to essential cells of 
the body and maintain metabolism [90].  However, the long-term impact of using these stores 
is loss of body weight, adipose tissue and lean muscle mass [90].  This is directly associated 
with the loss of physical reserves seen in frailty, and is independently associated with 
increased risk of mortality, morbidity, complications, and functional decline [30, 33, 90]. In 
addition to promoting decline of body stores of protein, frailty has been associated with 
declining micronutrient levels, such as iron, B vitamins, folate [91, 92]. 
There are a number of potential nutritional strategies to improve nutritional intake and build 
up nutrient stores to improve the potential to withstand future physiological stressors [89, 93].  
Consuming nutrient dense fluids and snacks between meals improves overall nutrient intake 
across the day, despite concern that between meal snacking will reduce intake at regular meal 
times [94]. Oral nutritional supplements (ONS) are commercially prepared drinks which are 
fortified to contain additional nutrients, especially energy and protein as well as other 
vitamins or minerals or bio-actives [95].  They are usually sold in tetra-packs, designed to be 
provided to patients with their mid-meal snacks or on their meal-trays aiming to bridge the 
gap between nutritional intake and estimated requirements.   
There is growing evidence supporting the use of nutritional strategies in older adults with or 
at risk of malnutrition to improve weight status and energy and protein intake [95].  In 
addition there is evidence that they can reduce mortality in patients identified as 
malnourished (RR 0.79 95% CI 0.64 to 0.97), although the effect on patients at risk of 
malnutrition remains under debate [95].  Following hip fracture, meta-analysis has shown an 
effect on the borderline of statistical significance for reducing mortality in patients (RR 0.52 
95% CI 0.25 to 1.07) [96].  However, the benefits of nutritional supplementation in some 
highly frail groups is still unclear, with no evidence of improvement in energy or protein 
intake, or lean mass in a group of nursing home residents following 10 weeks of ONS [97].  
Therefore, combinations of nutrition and exercise may be required to achieve gains in this 
group.  
But while nutritional strategies have been shown to improve oral intake, and body weight, 
follow on effects to functional status in frail older adults have not been clearly indicated.  
Daniels et al. [98] reviewed the literature for the effect of interventions to prevent disability 
in frail community dwelling older adults, as identified using the Ferrucci criteria [99], and 
found neither of the two trials including nutritional interventions showed a significant effect 
on disability level, despite improvements in total energy intake and weight gain. However, 
the nutritional intervention in one study [100] focused on improving micronutrient intake 
without first determining whether individuals were deficient in these vitamins and minerals. 
In addition, the nutritional intervention involved fortified foods that provided a set amount of 
additional energy (approx. 500kJ), protein, carbohydrates, and fat (amounts not reported) 
which may not have been sufficient or have been provided for long enough to promote 
improvement in frail older adults.  The other study identified [101] utilized ONS x 2 per day 
(providing an additional 2000-300kJ and 18 to 26g protein) for 16 weeks.  The study 
identified significant improvements in weight status and energy and protein intake, but no 
significant effects on strength or functional variables overall, although there was some 
improvement in TUG in women in the experimental group compared to the control group 
(24±20s vs 21±14s, p=0.04) and in men in knee extensor strength (211±50NW vs 
196±42NW, p=0.02), and the authors highlighted the importance of combining nutrition 
interventions with exercise interventions to achieve the most benefit on functional outcomes.  
In addition to treatment effects of multi-nutrient interventions, providing supplementary 
vitamin D has been studied in the older adult population for its effects on muscle strength and 
function and reducing falls [28]. The therapeutic benefit of vitamin D is likely through its 
ability to improve muscle and neurological function and subsequent reduction in falls, in 
addition reversing aged-related hyperparathyroidism and resultant reduction in bone mineral 
density [32]. While studies targeting frail older adults specifically are few, effectiveness in 
populations of older adults likely to be frail has been illustrated. Systematic review and meta-
analysis has shown the effect of supplementary vitamin D in the range of 200 to 1,000 IU on 
reducing falls (RR 0.86 95% CI 0.79 to 0.93) compared to calcium or placebo provision[102]. 
Improvements in muscle strength, and balance have been shown with daily doses of 800 to 
1000 IU[103] and reductions in mortality with supplementation of vitamin D and calcium 
(OR 0.94 95% IC 0.88 to 0.99). However, further studies illustrating the benefit to frail older 
adults specifically are needed to strengthen the basis for vitamin D supplementation in 
clinical practice for this group.  
Exercise therapy is a key intervention in the prevention and treatment of frailty in older 
adults, aiming to prevent decline in muscle mass, strength, and function [27, 104].  
Resistance training in particular is beneficial in combination with protein supplementation 
[105]. Overall, the benefits of exercise for older adults outweigh the risks for older adults of 
falling or suffering an injury during exercise [27, 104].   
Progressive resistance strength training is considered to be the key exercise intervention in 
the treatment of frailty however the exercises need to be continued to maintain effects.  Liu et 
al. [106] conducted a systematic review of the effects of progressive resistance strength 
training (PRT) exercises on older adults, either frail or fit and healthy.  They identified 121 
studies evaluating the effectiveness of PRT in predominantly community-dwelling older 
adults, although a few studies did focus on institutionalised older adults. PRT results in 
improvements in physical ability (SMD (standardised mean difference) = 0.14 95% CI 0.05 
to 0.22), gait speed (MD 0.08 m/s 95% CI 0.04 to 0.12), getting out of a chair (SMD = -0.94 
95% CI -1.49 and -0.68), and muscle strength (SMD = 0.84 95% CI 0.67 to 1.00). In addition 
there was a reduction in pain for those participants with osteoarthritis utilizing a disease 
specific instrument (SMD = -0.30, 95% CI -0.48 to -0.13), but no significant effect seen in 
other trials utilizing the bodily pain domains of the SF-36 health status measure (MD 0.34 
95% CI -3.44 to 4.12).  While the improvements of outcomes for older people from exercise 
in the short term is encouraging, information on the impact on outcomes in the long term is 
required as a key aspect to determine effectiveness.  Kennis et al. [107] evaluated the impact 
of resistance and aerobic training or whole-body vibration training in older adults, and found 
a significant improvement in static strength, dynamic strength, speed of movement in the 
intervention groups (p<0.001) compared to controls, however gains in these areas declined in 
a similar rate in the intervention and control groups once the intervention ceased.   
Exercise improves strength and balance but has also been shown to improve quality of life 
and functional independence. 
Chou et al. [104] undertook a systematic review and meta-analysis of the effect of exercise on 
physical function, ADLs, and quality of life in frail older adults.  The eight studies identified 
utilized a wide range of exercise interventions in frail older adults including flexibility, low- 
or intensive- resistance training, aerobic training, coordination training, balance exercises, 
Tai-Chi exercises, ADL based exercise regimes, and task orientated or gait training. Exercise 
programs generally lasted between 60 and 90 minutes, with frequency ranging from daily to 
weekly for between 3 and 12 months.  Their analysis identified a significant effect of exercise 
training on gait speed (WMD (Weighted Mean Difference) = 0.07m/s 95% CI 0.02 to 0.11, 
p=0.005), and on the Berg Balance Scale (WMD=1.7 95% CI 0.6 to 2.8, p=0.003) compared 
to controls given usual care but without exercise or with light or sham exercises.  In addition, 
they showed a significant effect of exercise interventions in improving performance in ADLs, 
measured by standardised questionnaires such as the Barthel Index, the FIM,  and the 
function subscale of the Functional Status Questionnaire (FSQ), (WMD=5.33, 95% CI 1.01 
to 9.64, p=0.34).     
How exercise interventions are best delivered to frail older people to maximise adherence and 
effects remains unclear.  Chin a Paw et al. [108] conducted a systematic review of the 
effectiveness of exercise interventions on physical function in frail older adults, and 
identified 20 studies in mostly community dwelling subjects (n=11) with the remainder from 
residential or supported care facilities or a combination of these (n=9).  Interventions 
evaluated included predominantly resistance training (n=9) or multi-component interventions 
(n=12) which included combinations of resistance training with other types such as balance, 
flexibility, and endurance training. The majority of the interventions took the form of facility-
based group exercise programs; however this was combined with a home-exercise program in 
five studies.  The frequency of the exercise program varied among the studies, but mostly 
was around three times per week, and lasted for between 10 weeks and 28 months.  The 
studies utilized a wide range of functional performance-based measures, and benefits were 
seen in most studies in at least one of these measures. Three out of four studies identified a 
significant improvement in a performance based score, such as the modified Physical 
Performance Test (PPT).  Over half of the studies that measured gait speed or a timed up and 
go (TUG) test (9 out of 17) identified significant improvements in their intervention group 
compared to their control groups. However six studies identified by the review did not show a 
positive effect of their intervention, perhaps due to intensity and duration of the interventions 
not being sufficient to show an improvement in older adults already identified as frail.  Nash 
et al. [109] updated this review up to September 2010, and identified 13 additional studies.  
Again a variety of interventions were utilized by the studies including multi-component 
interventions, as well as physical activity programs such as ballroom dancing and Tai Chi, 
functional training in specific functional tasks, progressive resistance training for lower limb 
muscles, and hydrotherapy.  Three studies (a functional training program, Tai-Chi, and a 
multi-component intervention) did not show a positive effect on any of the balance, gait, 
physical performance-based or ADL outcome measures utilized.  The remaining studies 
showed significant improvements in outcomes such as arm and lower limb strength, balance, 
flexibility, FIM scores, performance in the chair-stand test, gait speed, PPT, and fatigue in the 
intervention groups compared to the control groups, however generally the results of these 
studies were still heterogeneous and gains were not universal across all outcomes measured. 
The author identified some common factors in the successful interventions reviewed 
including multicomponent interventions targeting aspects of aerobic, balance, coordination, 
‘speed’ and resistance exercises across the program, a focus on higher-intensity and 
progressive exercise programs, frequency between 1 and 2 times per week and lasting for 
between 30 and 45 minutes, group classes with education to reinforce the importance of the 
exercise and focusing on activities enjoyable to the participants, support and encouragement 
from staff in residential or supported care, and frequent support for home based interventions 
to improve adherence.  
Recognising that frailty in older adults is multifactorial in cause, it is likely that patients will 
require treatment across a range of these modalities, and management of individual 
comorbidities [28, 110].  Patients are likely to need a variety of treatment tailored to the 
causes and effects of frailty in their individual cases [110].  Comprehensive geriatric 
assessment followed by an individualised multicomponent treatment has a strong evidence 
base and so not surprisingly is effective when applied to frail older adults.  Recent frailty 
focused trials utilize a range of treatments, including nutritional therapy, psychiatrist or 
psychologist input, interventions to reduce social isolation, and exercise therapy and show 
effects [110, 111].  One recent trial however showed that the effects take time to accrue so 
interventions need to be long term.  In this study the prevalence of frailty as measured by the 
Cardiovascular Health Study criteria was 14.7% lower in the intervention compared to the 
control group at 12 months. In addition, mobility measured by the Short Physical 
Performance Battery remained stable in the intervention group and declined in the control 
group (p<0.001). However, no differences were seen between the groups at three month 
follow up, highlighting the importance of long term treatment to allow sufficient time older 
adults to gain benefits.  
Practice Points 
• The prevalence of frailty in community-dwelling older adults ranges from 5 to 15% 
and the outcomes of this group are poor.   
• Problems with mobility and falls are an early marker that a person is becoming frail 
and should be assessed 
• Useful treatments include nutritional interventions and progressive resistance exercise 
training but multidisciplinary care which can include dietitians, physiotherapists, and 
psychologists is associated with better outcomes.  
• To identify who should receive multicomponent interventions simple screening tools 
for frailty are useful 
Research Agenda 
• While screening and assessment is being promoted, the models of screening methods, 
target populations, frequency, and treatment require further elicitation, especially the 
clinical and cost effectiveness of such strategies 
• Required duration and intensity of exercise and nutritional therapy to achieve the most 
long term benefit is still to be determined 
• Combinations of treatment considering the multifactorial nature of frailty may be 
more successful in older adults, however the best way of delivering interventions to 
achieve adherence needs further evaluation 
Summary 
Frailty and its associated functional decline is a growing problem across the health system, 
given the current aging of the population and its high correlation with older age.  However, 
other factors such as declining levels of physical activity and chronic disease play a role in its 
aetiology and are likely to be influencing its increasing prevalence as well. Conversely, the 
increasing prevalence of frailty is likely to impact upon the health system and the medical 
treatment of a range of conditions in the future, including musculoskeletal conditions, due to 
the influence of frailty on mortality, risk of complications and recovery and responsiveness to 
health interventions.  There is evidence of the effectiveness of exercise and nutritional 
therapy on preventing treating frailty; however the long term effects of these interventions are 
still to be determined. Future interventions may focus on combinations of therapy and a 
multidisciplinary approach to the treatment of this condition.   
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Table 1Rapid Screening tools for identifying frail patients 
Instrument/study Characteristics Scoring 
Simple “FRAIL” Questionnaire Screening 
Tool[112, 113] 
5 item self-report questionnaire focusing on: 
fatigue, aerobic fitness and strength, presence of 
comorbidities, and weight loss 
Meeting ≥3 criteria = Frail 
Meeting 1 or 2 criteria = prefrail 
Cardiovascular Health Study Frailty Screening 
Scale[10] 
5 item questionnaire with mixture of self-report 
and performance measures focusing on: weight 
loss, exhaustion, low activity levels, slowness in 
mobility, and weakness in grip strength 
Meeting ≥3 criteria = Frail 
Meeting 1 or 2 criteria = prefrail 
Clinical Frailty Scale [55] 9 item descriptive scale providing criteria for 
classifying people based on aspects of their fitness, 
general health, activity level, independence, 
mobility, level of comorbidity, frailty 
Clinical judgement 
Gérontopôle Frailty Screening Tool[54] 6 item questionnaire based on clinical opinion of 
physician focusing on: living status, weight loss, 





Table 2Assessment tools for measuring frailty 
Instrument/study Characteristics Scoring Measurement of mobility Measurement of 
strength 
Evaluative frailty index for physical activity 
(EFIP) [76] 
50 item Frailty Index. 
Self-report questionnaire 
Total score divided 
by the total number 
of questions (50).  




Assistance in transfers, 
assistance with mobility 
- 
Physical frailty phenotype (PFP), mental 
frailty phenotype (MFP) and social frailty 
phenotype (SFP) [11] 
18 item mixture of self-
report and physical 
performance measures 
and common geriatric 
assessment tools  
Greater or equal than 
2 criteria in the SFP 
and MFP and greater 
or equal than 4 
criteria in the PFP 
- - 





Difficulty in mobility Self-report poor 
grip strength 
Frailty phenotype/ [10] 5 item self-report 
questionnaire 
Those meeting ≥3 
criteria were 
categorised as frail, 
those meeting 1-2 
criteria as pre-frail, 
those meeting none 
of the criteria as 
robust 
Walking speed  Grip strength 
Frailty index, accumulation of deficits [25] A index of at least 40 
deficits including a mix 
of self-report and 
physical assessment and 
examination 
Total score divided 
by the total number 
of questions.  








Modified Functional Independence Measure 18 item self-report Range from 7 to 49 Transfers - 
(FIM) [61] questionnaire with higher score 
indicating greater 
frailty.  
Carriere Instrument [72] Combination of self-
report and performance 
tests 
Score from 25 to 165 
which is transformed 
on to a scale of 0 to 
1. Larger scores 
indicate greater risk 
of future 
dependency.  
Chair stand test, gait speed, 





‘Gealey’ Instrument[62] 13 item self-report 
questionnaire 
Score from 0 to 24, 
greater score indicate 
greater dependency.  
Walking, transfers - 
Groningen Frailty Indicator (GFI)[57] 15 item self-report 
questionnaire 
Score ranging from 0 
to 15, score of 4 or 
higher represents 
moderate to severe 
frailty.  
Walking (self-report) - 
Frail Elderly Functional Assessment 
Questionnaire[73] 
19 item self –report 
questionnaire 
Score ranging from 0 






‘Guilley’ Instrument[63] 17 item self-report 
questionnaire divided 
into five domains 
(sensory, mobility, 
physical pains, memory, 
energy) 
Scoring of each item 
range from 0 to 3. 
Score of 3 or higher 
for one item in the 
domains physical 
pains, memory and 
energy, or 2 or 
higher for one item 
in the sensory and 
mobility domains.  
Walking  - 
‘Rothman’ Instrument[70] 7 item questionnaire 
including self-report and 
physical performance 
Those meeting ≥3 
criteria were 
categorised as frail, 
Gait speed - 
measures those meeting 1-2 
criteria as pre-frail, 
those meeting none 
of the criteria as 
robust 
Clinical Global Impression of Change in 
Physical Frailty (CGIC-PF)[58] 
13 item instrument for 
use during geriatric  
assessment 
Scores ranging from 
1 to 7 with lower 
scores indicating 
greater decline in 
physical frailty 
Walking, transfers, stairs, 





The Vulnerable Elders Survey (VES)[64] 13 item self-report 
questionnaire 
Scores ranging from 
0 to 10, higher scores 
indicate greater 
frailty 
Walking Lifting 10lbs 
(self-report) 
Study of Osteoporotic Fractures (SOF) 
instrument[71] 
3 item questionnaire 
using a mixture of self-
report and physical 
testing 
Those meeting ≥2 
criteria were 
categorised as frail, 
those meeting 1 
criteria as pre-frail, 
those meeting none 
of the criteria as 
robust 
- Chair stand 
‘Chin A Paw’ Instrument[65] 2 item self-report 
questionnaire 
Those meeting the 2 
criteria classified as 
frail 
- - 
‘Puts’ Instrument[66] 9 item questionnaire 
combination of self-
report and physical 
performance tests 
Score ranging 
between 0 and 9, 
those meeting ≥3 
criteria classified as 
frail. 
- - 
Ravaglia Instrument[74] 9 item questionnaire 
combination of self-
report and physical 
performance tests 
Score ranging from 0 
to 9 with greater 
score indicating 
greater risk of 
mortality 
Tinetti gait and balance 
scale 
- 
Winograd Instrument[67] 15 item criteria covering 
comorbidities, physical 
and mental health, 
impairments, and social 
factors 
Score for frailty Impaired mobility - 





- Grip strength 
(Adapted from [19])
 
Table 3 Prevalence of frailty in community-dwelling older adult populations 





Frailty phenotype based on 
Fried et al. (2001) criteria 
Frail: 2.8% [5, 78] 9.8% [20], 16.9% 
[21], 7.2% [10] 
 
Pre-frail: 31.9%[20], 48.5%[21], 37.1% 
[78], 38.6[5], 47% [10] 
Study of Osteoporotic 
Fractures criteria (SOF) 
Frail: Men: 4.1% and Women 13.0% 
[115], 50% [4],  
Pre frail: 28% [4] 
Physical frailty phenotype 
(PFP), mental frailty 
phenotype (MFP), and 
social frailty phenotype 
(SFP) 
Frailty of any phenotype = 38.8% 






Figure 1: Schematic representation of the pathophysiology of frailty.  Taken from Clegg A, 
Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. The Lancet. 
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